Federal researchers have completed a study of the effectiveness of Eli Lilly’s antibody treatment for hospitalized COVID-19 patients due to a lack of efficacy. The National Institute for Allergy and Infectious Diseases (NIAID), which funded the study, announced late Monday that the treatment had received little clinical benefit from the …
Read More »NIH allely stops study of green antibody drug for treatment of hospitalized COVID-19 patients
